Novel Calcium Channel Modulators in RLS and Variants: Efficacy & Safety

NCT07453862 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Restless Leg Syndrome (RLS)
Variant Restless Legs Syndrome

Interventions

DRUG: Crisugabalin

Sponsor

Beijing Friendship Hospital